Cannabidiol (CBD) is a non-psychoactive phytocannabinoid known for its beneficial effects
including antioxidant and anti-inflammatory properties. Moreover, CBD is a compound with …

Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid derived from Cannabis
sativa. It has possible therapeutic effects over a broad range of neuropsychiatric disorders …

Cannabidiol (CBD), a nonpsychotropic phytocannabinoid that was once largely
disregarded, is currently the subject of significant medicinal study. CBD is found in Cannabis …

Cannabidiol (CBD) is a phytocannabinoid with a broad-range of therapeutic potential in
several conditions, including neurological (epilepsy, neurodegenerative diseases, traumatic …

As the major nonpsychotropic constituent of Cannabis sativa, cannabidiol (CBD) is regarded
as one of the most promising therapeutic agents due to its proven effectiveness in clinical …

Cannabis has a long history of anecdotal medicinal use and limited licensed medicinal use.
Until recently, alleged clinical effects from anecdotal reports and the use of licensed …

Despite the significant advances in neurology, the cure for neurodegenerative conditions
remains a formidable task to date. Among various factors arising from the complex etiology …

Background: Cannabidiol (CBD) is among the major secondary metabolites of Cannabis
devoid of the delta-9-tetra-hydrocannabinol psychoactive effects. It is a resorcinol-based …

Cannabidiol (CBD), the major nonpsychoactive Cannabis constituent, has been proposed
for the treatment of a wide panel of neurological and neuropsychiatric disorders, including …

Cannabidiol (CBD), derived from Cannabis sativa, has gained remarkable attention for its
potential therapeutic applications. This thorough analysis explores the increasing …